| Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL C Lavau, SJ Szilvassy, R Slany, ML Cleary The EMBO journal 16 (14), 4226-4237, 1997 | 450 | 1997 |
| A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification D Mueller, C Bach, D Zeisig, MP Garcia-Cuellar, S Monroe, A Sreekumar, ... Blood, The Journal of the American Society of Hematology 110 (13), 4445-4454, 2007 | 416 | 2007 |
| The molecular biology of mixed lineage leukemia RK Slany Haematologica 94 (7), 984, 2009 | 405 | 2009 |
| Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization BB Zeisig, T Milne, MP García-Cuéllar, S Schreiner, ME Martin, U Fuchs, ... Molecular and cellular biology 24 (2), 617-628, 2004 | 379 | 2004 |
| Association of SET domain and myotubularin-related proteins modulates growth control X Cui, ID Vivo, R Slany, A Miyamoto, R Firestein, ML Cleary Nature genetics 18 (4), 331-337, 1998 | 286 | 1998 |
| The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation M Birke, S Schreiner, MP García-Cuéllar, K Mahr, F Titgemeyer, RK Slany Nucleic acids research 30 (4), 958-965, 2002 | 270 | 2002 |
| The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX RK Slany, C Lavau, ML Cleary Molecular and cellular biology 18 (1), 122-129, 1998 | 269 | 1998 |
| Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications TA Milne, ME Martin, HW Brock, RK Slany, JL Hess Cancer research 65 (24), 11367-11374, 2005 | 223 | 2005 |
| Misguided transcriptional elongation causes mixed lineage leukemia D Mueller, MP García-Cuéllar, C Bach, S Buhl, E Maethner, RK Slany PLoS biology 7 (11), e1000249, 2009 | 221 | 2009 |
| Dimerization of MLL fusion proteins immortalizes hematopoietic cells ME Martin, TA Milne, S Bloyer, K Galoian, W Shen, D Gibbs, HW Brock, ... Cancer cell 4 (3), 197-207, 2003 | 205 | 2003 |
| Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia X Jiang, H Huang, Z Li, Y Li, X Wang, S Gurbuxani, P Chen, C He, D You, ... Cancer cell 22 (4), 524-535, 2012 | 195 | 2012 |
| Interaction of MLL amino terminal sequences with menin is required for transformation C Caslini, Z Yang, M El-Osta, TA Milne, RK Slany, JL Hess Cancer research 67 (15), 7275-7283, 2007 | 195 | 2007 |
| c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells JL Hess, CB Bittner, DT Zeisig, C Bach, U Fuchs, A Borkhardt, J Frampton, ... Blood 108 (1), 297-304, 2006 | 184 | 2006 |
| Leukemogenic transformation by HOXA cluster genes C Bach, S Buhl, D Mueller, MP García-Cuéllar, E Maethner, RK Slany Blood, The Journal of the American Society of Hematology 115 (14), 2910-2918, 2010 | 158 | 2010 |
| The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin DT Zeisig, CB Bittner, BB Zeisig, MP García-Cuéllar, JL Hess, RK Slany Oncogene 24 (35), 5525-5532, 2005 | 142 | 2005 |
| MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia X Jiang, H Huang, Z Li, C He, Y Li, P Chen, S Gurbuxani, S Arnovitz, ... Proceedings of the National Academy of Sciences 109 (47), 19397-19402, 2012 | 141 | 2012 |
| AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia F Zhou, Y Liu, C Rohde, C Pauli, D Gerloff, M Köhn, D Misiak, N Bäumer, ... Nature cell biology 19 (7), 844-855, 2017 | 136 | 2017 |
| When epigenetics kills: MLL fusion proteins in leukemia RK Slany Hematological oncology 23 (1), 1-9, 2005 | 120 | 2005 |
| A new function of S-adenosylmethionine: the ribosyl moiety of AdoMet is the precursor of the cyclopentenediol moiety of the tRNA wobble base queuine RK Slany, M Boesl, PF Crain, H Kersten Biochemistry 32 (30), 7811-7817, 1993 | 120 | 1993 |
| MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia SC Monroe, SY Jo, DS Sanders, V Basrur, KS Elenitoba-Johnson, ... Experimental hematology 39 (1), 77-86. e5, 2011 | 102 | 2011 |
